Finalists Invited to Next Stage of Learning Competition
April 9, 2012 — Today BloodTechNet announced the finalists for the second annual Learning Competition, a unique initiative to find — and inspire — innovative projects that support learning among Canadian medical laboratory technologists interested in Transfusion Science.
Over the past six weeks, numerous ideas designed to improve and broaden the continuing education options available to MLTs have been submitted from across the country. Our elite panel of judges have reviewed, deliberated, scored and ranked the submissions, and decided which top applicants will move on to the next stage.
There is one important change in this year's competition. Because we received only one-third of the expected number of applications, this year we will be reducing the BloodTechNet Fund to $75,000. Our goal remains: give MLTs the choice as to which projects they wish to see funded.
Seven finalists have been invited to advance to the next stage and provide details about their projects. They will have an opportunity to describe their goals and activities, post samples of their work and respond to questions and feedback until April 23, 2012. Then, in final stage of the competition, MLTs will vote on which projects should share the BloodTechNet fund. The Learning Competition winners will be announced during the CSTM conference and on BloodTechNet.ca in mid-May.
The finalists invited to Stage 2 are listed below by budget size:
Large Ideas ($15K - $25K)
- Antibody Identification
- Crowdsourced Continuing Education Website for Transfusion Technologists
- Quality in the Lab – What Does It Mean To Me?
Medium Ideas ($5K - $15K)
- 'I will remember you' (Once in a lifetime mentoring opportunity)
- SOPs that Hinder; SOPs that Help
Small Ideas (up to $5K)
- Month to Month Calendar - Advanced Blood Bank Review
— 30 —
BloodTechNet is a not-for-profit learning network for medical laboratory technologists interested in Transfusion Science. The Learning Competition is our way of supporting MLTs in the transfusion community. It is administered by Canadian Blood Services, with unrestricted funding provided by Grifols.